Alnylam Pharmaceuticals (ALNY) Cash from Financing Activities (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Cash from Financing Activities of $36.24 million for Q2 2026, down 53.4% from $77.68 million a year earlier but up 130.6% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Alnylam Pharmaceuticals was -$377 million; for FY2025, it was -$305.19 million.
- In prior years, Alnylam Pharmaceuticals' Cash from Financing Activities was $294.16 million in FY2024 (+70.9%), $172.13 million in FY2023 (-59.6%), $425.75 million in FY2022 (-65.9%) and $1.25 billion in FY2021 (+25.3%).
- Quarterly Cash from Financing Activities has run from a low of -$474.27 million in Q3 2025 to a high of $573.84 million in Q3 2021 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in three of the last seven quarters, with growth averaging 19.2%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2024, with growth of 210.1%; the weakest was Q2 2022, with a decline of 90.8%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $15.71 million (Q1 2026), $45.32 million (Q4 2025) and -$474.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 36.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.24 Mn |
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | 45.32 Mn |
| Sep 30, 2025 | -474.27 Mn |
| Jun 30, 2025 | 77.68 Mn |
| Mar 31, 2025 | 46.08 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 102.76 Mn |
| Jun 30, 2024 | 131.50 Mn |
| Mar 31, 2024 | 28.91 Mn |
| Dec 31, 2023 | 39.23 Mn |
| Sep 30, 2023 | 33.14 Mn |
| Jun 30, 2023 | 53.39 Mn |
| Mar 31, 2023 | 46.37 Mn |
| Dec 31, 2022 | 63.44 Mn |
| Sep 30, 2022 | 297.02 Mn |
| Jun 30, 2022 | 30.34 Mn |
| Mar 31, 2022 | 34.96 Mn |
| Dec 31, 2021 | 292.29 Mn |
| Sep 30, 2021 | 573.84 Mn |
API Access
Alnylam Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();